How should we manage Empyema complicating tunneled pleural catheter placement?

Journal of Bronchology and Interventional Pulmonology

Volumn 17, Issue 2, 2010, Pages 106-108

  Tremblay, Alain ^a   Stather, David R ^a   MacEachern, Paul ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFAZOLIN; CLINDAMYCIN; CLOXACILLIN; FIBRINOLYTIC AGENT; LACTATE DEHYDROGENASE;

CATHETER; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER REMOVAL; CELLULITIS; DECORTICATION; EDITORIAL; EMPYEMA; HOSPITAL INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PLEURA EFFUSION; PLEURA FLUID; PLEURODESIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; THORACOCENTESIS; THORACOSCOPY; THORAX DRAINAGE; TUNNELED PLEURA CATHETER; WOUND DRAINAGE; WOUND HEALING; WOUND INFECTION;

EID: 77951709452     PISSN: 19446586     EISSN: 19488270     Source Type: Journal    
DOI: 10.1097/LBR.0b013e3181dab03d     Document Type: Editorial

References (13)

1. Stather DR, Tremblay A. Use of tunneled pleural catheters for outpatient treatment of malignant pleural effusions. Curr Opin Pulm Med. 2007;13:328-333. (Pubitemid 46847300)
2. Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest. 2006;129:362-368.
3. Putnam JB Jr, Light RW, Rodriguez RM, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999;86: 1992-1999.
4. Putnam JB Jr, Walsh GL, Swisher SG, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg. 2000;69: 369-375.
5. Warren WH, Kim AW, Liptay MJ. Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion. Eur J Cardiothorac Surg. 2008;33:89-94.
6. Stefani A, Natali P, Casali C, et al. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study. Eur J Cardiothorac Surg. 2006;30:827-832.
7. de Campos JRM, Vargas FS, Werebe EdC, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest. 2001;119:801-806.
8. Viallat JR, Rey F, Astoul P, et al. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest. 1996;110:1387-1393.
9. Arapis K, Caliandro R, Stern JB, et al. Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients. Surg Endosc. 2006;20: 919-923.
10. Dresler CM, Olak J, Herndon JE, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005; 127:909-915.
11. Mahmood K, Bower C. Treatment of infection associated with tunneled pleural catheters. J Bronchol Intervent Pulmonol. 2010;17:69-72.
12. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions. Chest. 2000;118:1158-1171.
13. Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2008. CD002312.